Page 834 - Veterinary Immunology, 10th Edition
P. 834

VetBooks.ir  Production, Presentation, and Control




               of Vaccines



               The production of veterinary vaccines is controlled by the Animal
               and Plant Health Inspection Service of the United States
               Department of Agriculture; by the Canadian Centre for Veterinary
               Biologics of the Canadian Food Inspection Agency; and by the

               Veterinary Medicines Directorate in the United Kingdom; as well as
               by appropriate government agencies in other countries. In general,
               regulatory authorities have the right to license establishments
               where vaccines are produced and to inspect these premises to

               ensure that the facilities are appropriate and that the methods
               employed are satisfactory. All vaccines must be checked for safety
               and potency. Safety tests include confirmation of the identity of the
               organism used and of the freedom of the vaccine from extraneous

               organisms (i.e., purity), as well as tests for toxicity and sterility.
               Because the living organisms or antigens found in vaccines
               normally die or degrade over a period of time, it is necessary to
               ensure that they will be effective even after storage. It is usual,

               therefore, to use an antigen in generous excess of the dose required
               to protect animals under laboratory conditions, and potency is
               tested both before and after accelerated aging. Vaccines that contain
               killed organisms, although much more stable than living ones, also

               contain an excess of antigens for the same reason. Vaccines
               approved for licensing on the basis of challenge exposure studies
               must usually show evidence of protection in 80% of vaccinated
               animals, whereas at least 80% of the unvaccinated controls must

               develop evidence of disease after challenge exposure (the 80 : 80
               efficacy guideline). The route and dose of administration indicated
               on the vaccine label should be scrupulously heeded since these
               were probably the only route and dose tested for safety and efficacy

               during the licensing process. Vaccines usually have a designated
               shelf-life, and although properly stored vaccines may still be potent
               after the expiration of this shelf-life, this should never be assumed.
               Correct storage and handling are essential. All expired vaccines

               should be discarded. Adverse reactions should always be reported





                                                         834
   829   830   831   832   833   834   835   836   837   838   839